2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
½Å¿¹ ¼Û°­, SBS ÀαⰡ¿ä MC ¹ßŹ (2018-02-19)
Á¤º¸È­¸¶À» Æä½ºÅ¸(Festa)¿¡¼­ ¸¸³³½Ã´Ù (2012-10-31)
¼­¿ï, Àü ¼¼°è »ý°èºñ ºñ½Ñ µµ½Ã 11À§ (2020-06-09)
ÄÚÆÃ 1ȸ·Î 1³â°£ Äڷγª µî Áõ½Ä ¸·´Â Ç×±ÕÁ¦ (2020-05-23)
Çѱ¹ÀâÁöÇùȸ, ±ÙÇö´ëÀâÁö Ưº°Àü °³ÃÖ (2022-11-01)
Çö´ëÂ÷, ºí·ç¸â¹ö½º ´©Àû ȸ¿ø 1000¸¸ µ¹ÆÄ À̺¥Æ® (2022-11-01)
¸£³ëÆÄÀ̳½¼È, ¡®¸ðºô¶óÀÌÁîÆÄÀ̳½¼È¡¯·Î ºê·£µå º¯°æ (2022-11-01)
½Ã°ñÅõ¾î, ¡®GREAT ȫõ¡¯ ÆÔÅõ¾î ½Ç½Ã (2019-06-01)
¾ÖÇÃ, ¡®2022 ±Û·Î¹ú Åé 100 ºê·£µå¡¯ 1À§ (2022-06-18)
¼­¿ïµå·¡°ï½ÃƼ ´õ ¸®º», ¡®¼ÎÇÁ Å×À̽ºÆÃ ¸Þ´º¡¯ ¼±º¸¿© (2018-12-30)
õ±ÇÁ¸®¹Ì¾ö ¡®LG ½Ã±×´Ïó¡¯ ´ë¸¸ ÇÁ¸®¹Ì¾ö ½ÃÀå °ø·« (2018-09-19)
¸ðµ¨ ÁøÁÖºñ, 3³â °ø¹é±â ±ú°í È­º¸·Î ÄĹé (2022-02-19)
¾Ë¹Ù»ý 46.7%, °è¾à±â°£ ³²¾ÒÁö¸¸ Åð»çÇÑ Àû ÀÖ¾î (2018-06-09)
ÃÖ°­Ã¢¹Î, º¸È£Á¾·á¾Æµ¿ Áö¿ø¿¡ 3õ¸¸ ¿ø ±âºÎ (2021-12-30)
Á÷ÀåÀÎ ¡®Äڷγª ½Ã´ë, ±Ù¹« ȯ°æ º¯È­ ±àÁ¤Àû' (2021-11-26)
'D.P ¼­´ëÀ§' Á¶Á¤È¯, ¿¬±ØÀο¡¼­ ´Ê±ïÀÌ ¹è¿ì·Î (2021-10-06)
µ¥½ºÄ¿ ¸â¹ö½Ê ºñÄ¡ ¶ó¿îÁö (2021-08-16)
Çѱ¹º¸°Çº¹ÁöÀη°³¹ß¿ø, ±¹¹Î±âȹ´Ü ¸ðÁý (2021-05-23)
ÀÏ»ê ŲŨ½º , ¶±ººÀÌ ½Ò¸é¿¡ »ç·Î ÀâÈ÷´Ù (2012-11-16)
Á÷ÀåÀΠù ÀÌÁ÷ ½Ã±â »¡¶óÁ³´Ù (2021-04-02)
³» ¸¶À½ÀÇ ¿µ¹®¹ý, 5Çü½Ä ¶Ù¾î³Ñ±â (2021-01-24)
¹è¿ì ¼ºÈÆ, ³óÃÌÀ¶º¹ÇÕ»ê¾÷ ±¤°í¸ðµ¨·Î ¹ßŹ (2020-12-04)
GS25, GS¼¥°ú ¼ÕÀâ°í ÁÖ·ù ½º¸¶Æ® ¿À´õ ½ÃÇà (2020-06-17)
¼­¿ï½Ã, û³â À§ÇÑ ºí·çÅÍÄ¡ Äܼ­Æ® ¡®¼±¹°¡¯ °³ÃÖ (2019-05-23)
CJÁ¦ÀÏÁ¦´ç, »Ú¶ìÿ ³Ãµ¿ ÄÉÀÌÅ© Ãâ½Ã (2019-01-24)
       [ÀÌÀü][1]....[2616][2617][2618][2619][2620][2621][2622][2623][2624]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..